Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,971 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion.
Franco R, Zappavigna S, Gigantino V, Luce A, Cantile M, Cerrone M, Facchini G, Perdonà S, Pignata S, Di Lorenzo G, Chieffi S, Vitale G, De Sio M, Sgambato A, Botti G, Yousif AM, Novellino E, Grieco P, Caraglia M. Franco R, et al. J Exp Clin Cancer Res. 2014 Jun 3;33(1):48. doi: 10.1186/1756-9966-33-48. J Exp Clin Cancer Res. 2014. PMID: 24893613 Free PMC article.
Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma.
Zito Marino F, Liguori G, Aquino G, La Mantia E, Bosari S, Ferrero S, Rosso L, Gaudioso G, De Rosa N, Scrima M, Martucci N, La Rocca A, Normanno N, Morabito A, Rocco G, Botti G, Franco R. Zito Marino F, et al. Among authors: franco r. PLoS One. 2015 Sep 30;10(9):e0139264. doi: 10.1371/journal.pone.0139264. eCollection 2015. PLoS One. 2015. PMID: 26422230 Free PMC article.
A new look at the ALK gene in cancer: copy number gain and amplification.
Zito Marino F, Rocco G, Morabito A, Mignogna C, Intartaglia M, Liguori G, Botti G, Franco R. Zito Marino F, et al. Among authors: franco r. Expert Rev Anticancer Ther. 2016 May;16(5):493-502. doi: 10.1586/14737140.2016.1162098. Epub 2016 Apr 6. Expert Rev Anticancer Ther. 2016. PMID: 26943457 Review.
Crizotinib Response in a Late Relapse of ALK-positive Lung Adenocarcinoma.
Zito Marino F, Morabito A, Gridelli C, Rocco G, Liguori G, De Rosa N, Botti G, Franco R. Zito Marino F, et al. Among authors: franco r. Appl Immunohistochem Mol Morphol. 2016 Oct;24(9):e86-e88. doi: 10.1097/PAI.0000000000000328. Appl Immunohistochem Mol Morphol. 2016. PMID: 26990744
1,971 results